These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7494407)

  • 21. Progress toward generating a ferret model of cystic fibrosis by somatic cell nuclear transfer.
    Li Z; Engelhardt JF
    Reprod Biol Endocrinol; 2003 Nov; 1():83. PubMed ID: 14613541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR.
    Zhou L; Dey CR; Wert SE; DuVall MD; Frizzell RA; Whitsett JA
    Science; 1994 Dec; 266(5191):1705-8. PubMed ID: 7527588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease.
    Liu Y; Wang Y; Jiang Y; Zhu N; Liang H; Xu L; Feng X; Yang H; Ma T
    Biochem Biophys Res Commun; 2008 Aug; 373(1):113-8. PubMed ID: 18555011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal enamel development in a cystic fibrosis transgenic mouse model.
    Wright JT; Kiefer CL; Hall KI; Grubb BR
    J Dent Res; 1996 Apr; 75(4):966-73. PubMed ID: 8708137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis.
    Amaral MD; Kunzelmann K
    Trends Pharmacol Sci; 2007 Jul; 28(7):334-41. PubMed ID: 17573123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.
    Olivier AK; Gibson-Corley KN; Meyerholz DK
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G459-71. PubMed ID: 25591863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "Goldilocks effect" in cystic fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse.
    Cohen JC; Lundblad LK; Bates JH; Levitzky M; Larson JE
    BMC Genet; 2004 Jul; 5():21. PubMed ID: 15279681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A murine model of cystic fibrosis.
    Snouwaert JN; Brigman KK; Latour AM; Iraj E; Schwab U; Gilmour MI; Koller BH
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S59-64. PubMed ID: 7533607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of cftr function leads to pancreatic destruction in larval zebrafish.
    Navis A; Bagnat M
    Dev Biol; 2015 Mar; 399(2):237-48. PubMed ID: 25592226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New perspectives and hope for cure-reflecting recent genetic developments in cystic fibrosis.
    Midro AT; Kulczycki LL
    Mater Med Pol; 1992; 24(4):253-5. PubMed ID: 1308055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drugs for cystic fibrosis.
    Wilschanski M; Kerem E
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1285-92. PubMed ID: 21745147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystic fibrosis in the mouse by targeted insertional mutagenesis.
    Dorin JR; Dickinson P; Alton EW; Smith SN; Geddes DM; Stevenson BJ; Kimber WL; Fleming S; Clarke AR; Hooper ML
    Nature; 1992 Sep; 359(6392):211-5. PubMed ID: 1382232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
    Salvatore F; Scudiero O; Castaldo G
    Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gene therapy perspectives in cystic fibrosis].
    Midro AT; Kulczycki LL; Sledziewski A
    Postepy Hig Med Dosw; 1993; 47(4):221-30. PubMed ID: 8309849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K; Taylor-Cousar JL
    Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse as a model of growth retardation in cystic fibrosis.
    Rosenberg LA; Schluchter MD; Parlow AF; Drumm ML
    Pediatr Res; 2006 Feb; 59(2):191-5. PubMed ID: 16439577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
    Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
    Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model.
    Cohen JC; Morrow SL; Cork RJ; Delcarpio JB; Larson JE
    Mol Genet Metab; 1998 Jun; 64(2):108-18. PubMed ID: 9705235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.